600381.SH
Qinghai Spring Medicinal Resources Technology Co. Ltd.
SSE · Energy · Coal · CN
CNY 4.75
−3.85%Year over year
Reported trailing growth
- Revenue
- +12.8%
- EBITDA
- —
- EBIT
- +71.4%
- EPS
- +59.4%
- Free cash flow
- +283.9%
- Operating cash flow
- +405.5%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +28.9%
- EBITDA
- +97.4%
- EBIT
- +87.1%
- Net income
- +81.2%
- EPS
- +79.4%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026